Trial intelligence / Profile preview

High Dose Recombinant Hepatitis B Vaccine in Hemodialysis Patients

NCT02963714Phase 4Completed

Start
Dec 2014
Primary completion
Jul 2015
Modality
Vaccines & Immunotherapeutics
01

Overview

A Phase 4 trial of recombinant hepatitis B vaccine Bio Farma in hepatitis B (HBV). Started Dec 2014; status: completed.

02

Drugs

recombinant hepatitis B vaccine Bio Farma
03

Conditions

hepatitis B (HBV)

Beyond the preview

Go deeper on NCT02963714.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02963714.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call